Home › Funds › Parkman Healthcare Partners LLC › CRL
Parkman Healthcare Partners LLC position in CRL
CHARLES RIV LABS INTL INC · Health Care
Parkman Healthcare Partners LLC reported holding 60,000 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$17.7M, representing 1.60% of its reported portfolio and ranking #18 among its reported holdings. Parkman Healthcare Partners LLC has disclosed CRL holdings in 3 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's CRL position evolved
Parkman Healthcare Partners LLC first disclosed a stake in CRL in Q3 2023 at 44,160 shares (US$8.7M). The position peaked in Q3 2026 at 60,000 shares, worth US$17.7M. Across 3 filings, Parkman Healthcare Partners LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 60,000 shares valued at US$17.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 44.16K | $8.65M | New |
| Q1 2024 | 17.70K | $4.80M | New |
| Q3 2026 | 60.00K | $17.70M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 31 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M sh · $320.67M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K sh · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held CRL?
Parkman Healthcare Partners LLC has disclosed CRL holdings in 3 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in CRL?
As of Q3 2026, Parkman Healthcare Partners LLC holds 60.00K shares of CRL (CHARLES RIV LABS INTL INC), valued at $17.70M, representing 1.60% of its reported portfolio and ranking #18.
Has Parkman Healthcare Partners LLC been buying or selling CRL?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC newly opened its position in CRL. The position peaked in Q3 2026 at 60.00K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.